Vaxcyte’s 31-strain pneumococcal conjugate vaccine passes phase 3 test
Panuwat Dangsungnoen / iStock Vaccine maker Vaxcyte this week introduced constructive topline outcomes from a part 3 trial of its ...
Panuwat Dangsungnoen / iStock Vaccine maker Vaxcyte this week introduced constructive topline outcomes from a part 3 trial of its ...
The way forward for value-based care will hinge on empowering suppliers, and specialists particularly, with the information and strategic partnerships ...
GSK mentioned the blended Section 3 outcomes for camlipixant imply this capsule “is unlikely to remodel affected person care” in ...
AstraZeneca and Ionis Prescription drugs drug eplontersen, model identify Wainua, failed a Part 3 check in cardiomyopathy attributable to transthyretin ...
Roche’s divarasib was designed supply higher efficiency and selectivity to KRAS G12C in comparison with first-generation medicine on this class ...
An experimental six-strain Lyme vaccine has demonstrated greater than 70% efficacy in stopping Lyme illness in individuals aged 5 years ...
Construction Therapeutics’ aleniglipron, a once-daily oral GLP-1 drug, led to a mean 16% weight reduction measured at 44 weeks. Primarily ...
The antiviral drug tecovirimat (Tpoxx) is not any higher than placebo in attaining a shorter time to scientific decision, lowered ...
A BridgeBio Pharma drug developed for dwarfism elevated youngsters’s progress charges in a pivotal medical trial, assembly the research’s fundamental ...
The Trump administration is asking Gavi, the Vaccine Alliance, to part out using vaccines containing the preservative thimerosal if it ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.